Macbon Chemist Limited SC333249 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is Dispensing chemist Digita Accounts Production Advanced 6.30.9574.0 true SC333249 2024-05-01 2025-04-30 SC333249 2025-04-30 SC333249 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2025-04-30 SC333249 core:CurrentFinancialInstruments 2025-04-30 SC333249 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 SC333249 core:Non-currentFinancialInstruments core:AfterOneYear 2025-04-30 SC333249 core:FurnitureFittingsToolsEquipment 2025-04-30 SC333249 core:MotorVehicles 2025-04-30 SC333249 core:OtherPropertyPlantEquipment 2025-04-30 SC333249 bus:SmallEntities 2024-05-01 2025-04-30 SC333249 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 SC333249 bus:FilletedAccounts 2024-05-01 2025-04-30 SC333249 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 SC333249 bus:RegisteredOffice 2024-05-01 2025-04-30 SC333249 bus:Director1 2024-05-01 2025-04-30 SC333249 bus:Director2 2024-05-01 2025-04-30 SC333249 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-05-01 2025-04-30 SC333249 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 SC333249 bus:Agent1 2024-05-01 2025-04-30 SC333249 core:Goodwill 2024-05-01 2025-04-30 SC333249 core:FurnitureFittingsToolsEquipment 2024-05-01 2025-04-30 SC333249 core:MotorVehicles 2024-05-01 2025-04-30 SC333249 core:OtherPropertyPlantEquipment 2024-05-01 2025-04-30 SC333249 core:OtherRelatedParties 2024-05-01 2025-04-30 SC333249 countries:Scotland 2024-05-01 2025-04-30 SC333249 2024-04-30 SC333249 core:FurnitureFittingsToolsEquipment 2024-04-30 SC333249 core:MotorVehicles 2024-04-30 SC333249 core:OtherPropertyPlantEquipment 2024-04-30 SC333249 2023-05-01 2024-04-30 SC333249 2024-04-30 SC333249 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-04-30 SC333249 core:CurrentFinancialInstruments 2024-04-30 SC333249 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 SC333249 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-30 SC333249 core:FurnitureFittingsToolsEquipment 2024-04-30 SC333249 core:MotorVehicles 2024-04-30 SC333249 core:OtherPropertyPlantEquipment 2024-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC333249

Macbon Chemist Limited
Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 April 2025

Macbon Chemist Limited

Contents

Company Information | 1
Directors' Report | 2
Accountants' Report | 3
Abridged Balance Sheet | 4 to 5
Notes to the Unaudited Abridged Financial Statements | 6 to 11

Macbon Chemist Limited

Company Information

Directors | Mr Ronald Adrian Badger Mrs Lynne Barbara Badger

Registered office | 3 Bank Avenue Milngavie Glasgow Lanarkshire G62 8NG

Accountants | Hamilton Morris Waugh Chartered Certified Accountants34 Dufferin Avenue Bangor Down BT20 3AA

Macbon Chemist Limited

Directors' Report for the Year Ended 30 April 2025

The directors present their report and the abridged financial statements for the year ended 30 April 2025.

Directors of the company

The directors who held office during the year were as follows:

Mr Ronald Adrian Badger

Mrs Lynne Barbara Badger

Principal activity

The principal activity of the company is Dispensing chemist

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:

......................................... Mr Ronald Adrian Badger Director

Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Macbon Chemist Limited
for the Year Ended 30 April 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Macbon Chemist Limited for the year ended 30 April 2025 as set out on pages 4 to 11 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants (ACCA), we are subject to its ethical and other professional requirements.

This report is made solely to the Board of Directors of Macbon Chemist Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Macbon Chemist Limited and state those matters that we have agreed to state to the Board of Directors of Macbon Chemist Limited, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Macbon Chemist Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Macbon Chemist Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Macbon Chemist Limited. You consider that Macbon Chemist Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Macbon Chemist Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
Hamilton Morris Waugh
Chartered Certified Accountants
34 Dufferin Avenue
Bangor
Down
BT20 3AA

30 September 2025

Macbon Chemist Limited

(Registration number: SC333249)
Abridged Balance Sheet as at 30 April 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 5 | 81,120 | 108,195
Current assets |  |  |
Stocks | 6 | 31,000 | 43,144
Debtors |  | 672,992 | 346,182
Cash at bank and in hand |  | 156,390 | 138,927
|  | 860,382 | 528,253
Prepayments and accrued income |  | 1,252 | -
Creditors: Amounts falling due within one year |  | (348,647) | (211,429)
Net current assets |  | 512,987 | 316,824
Total assets less current liabilities |  | 594,107 | 425,019
Creditors: Amounts falling due after more than one year |  | (10,017) | (13,552)
Provisions for liabilities |  | (20,280) | (4,489)
Accruals and deferred income |  | (813) | (678)
Net assets |  | 562,997 | 406,300
Capital and reserves |  |  |
Called up share capital | 7 | 2 | 2
Retained earnings |  | 562,995 | 406,298
Shareholders' funds |  | 562,997 | 406,300

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account and Directors' Report.

Macbon Chemist Limited

(Registration number: SC333249)
Abridged Balance Sheet as at 30 April 2025

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:

......................................... Mr Ronald Adrian Badger Director

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

1 | General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
3 Bank Avenue
Milngavie
Glasgow
Lanarkshire
G62 8NG
Scotland

These financial statements were authorised for issue by the Board on 30 September 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.
Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.
Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 13 (2024 - 11).

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

4 | Intangible assets

| Total £
Cost or valuation
At 1 May 2024 | 200,000
At 30 April 2025 | 200,000
Amortisation
At 1 May 2024 | 200,000
At 30 April 2025 | 200,000
Carrying amount
At 30 April 2025 | -

5 | Tangible assets

| Furniture, fittings and equipment £ | Motor vehicles £ | Other tangible assets £ | Total £
Cost or valuation
At 1 May 2024 | 96,359 | 8,737 | 21,762 | 126,858
Additions | - | - | 997 | 997
Disposals | - | (8,737) | - | (8,737)
At 30 April 2025 | 96,359 | - | 22,759 | 119,118
Depreciation
At 1 May 2024 | 9,708 | 7,595 | 1,360 | 18,663
Charge for the year | 21,663 | 143 | 5,267 | 27,073
Eliminated on disposal | - | (7,738) | - | (7,738)
At 30 April 2025 | 31,371 | - | 6,627 | 37,998
Carrying amount
At 30 April 2025 | 64,988 | - | 16,132 | 81,120
At 30 April 2024 | 86,651 | 1,142 | 20,402 | 108,195

6 | Stocks

| 2025 £ | 2024 £
Finished goods and goods for resale | 31,000 | 43,144

Macbon Chemist Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

7 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Share Capital of £1 each | 2 | 2 | 2 | 2

8 | Related party transactions

Summary of transactions with other related parties

Ron Badger
Director
At the Balance Sheet date, the company owed the director £71,364 (2024: £2,106).